Annual Development Plan. Not later than sixty (60) days after December 31 of each Calendar Year, Licensee shall submit to Merck an updated Development Plan for the pending Calendar Year. Such update shall take into account completion, commencement, changes in or cessation of Development activities not contemplated by the then-current Development Plan in sufficient detail to reflect the Commercially Reasonable Efforts of Licensee or a Related Party for the Development of Licensed Product in the Field. Merck shall have the right to comment on such annual plan. In the event Merck reasonably disagrees with the plan, Licensee shall in good faith consider Merck’s comments for revising the plan; provided, however, that Licensee shall not be obligated to incorporate such Merck comments and Licensee retains final decision making authority with respect to all such plans.
Annual Development Plan. The Development Phase shall be conducted under an annual development plan which shall describe the work to be pursued by MMD and TKT under the supervision of the Development Committee with respect to the development of GA-EPO. The first Development Plan will be prepared by MMD for submission to the Development Committee within ********************************************************** ****************************************************************. Thereafter, the annual development plan will be prepared by MMD for submission to the Development Committee no later than ****** ********* prior to the beginning of each calendar year.
Annual Development Plan. 7.1 The Partners shall prepare an Annual Development Plan for the Services at least twelve (12) weeks before the start of the Financial Year. The Annual Development Plan shall:
7.1.1 set out the agreed aims and outcomes for the Services;
7.1.2 describe any changes or development required for the Services;
7.1.3 provide information on how changes in funding or resources may impact the Services; and
7.1.4 include details of the estimated contributions due from each Partner for the Services and its designation to the Pooled Fund.
7.2 The Annual Development Plan shall commence on 1 April at the beginning of the Financial Year and shall continue for 12 months.
7.3 The Annual Development Plan may be varied by written agreement between the Lead Partner and the Authority. Any variation that increases or reduces the number or level of Services in the scope of the Agreement shall require the Partners to make corresponding adjustments to the NHS Bodies’ Financial Contribution and the Authority's Financial Contribution.
7.4 If the Partners cannot agree the contents of the Annual Development Plan, the matter shall be dealt with in accordance with the Dispute Resolution Procedure. Pending the outcome of the Dispute Resolution Procedure or termination of the Agreement under clause 27, the Partners shall make available amounts equivalent to the Financial Contributions for the previous Financial Year.
Annual Development Plan. No later than [***] days after the end of each Calendar Year, Tigercat shall submit to Merck an updated Development Plan for the then current Calendar Year. Such update shall take into account completion, commencement, changes in or cessation of Development activities in sufficient detail to reflect the continued diligence of Tigercat. Merck shall have the right to comment on such updated Development Plan, but Tigercat shall have sole decision-making rights with respect to such Development Plan.
Annual Development Plan. The Development Program shall be conducted under an annual research and development plan (the "Annual Development Plan") which shall reasonably describe the work to be pursued by the Joint Steering Committee and to be conducted by Metasyn and MKG with respect to the development of the Licensed Compound, any Second Generation Compounds, the Replacement Compounds and any Outside Compounds and the corresponding Licensed Products. The Annual Development Plan shall contain a budget including estimates of the aggregate Development Costs of both Parties to be incurred during the applicable year. The Annual Development Plan will incorporate the Base Case Scenario Model (as the model may have been amended by the Joint Steering Committee in accordance with Section 6.1 hereof and as it may be applicable). The first Annual Development Plan describing the expenses and activities anticipated for the period between the Effective Date and December *Confidential information omitted and filed with the Commission. 11
Annual Development Plan. Not later than sixty (60) days after December 31 of each Calendar Year, Licensee shall submit to Lilly an updated Development Plan for the pending Calendar Year. Such update shall take into account the anticipated Development activities, for the applicable development period, of Licensee or a Related Party for the Development of Licensed Product in the Field. Lilly shall have the right to comment on such annual plan, provided, however, that Licensee shall not be obligated to incorporate such Lilly comments and Licensee retains final decision making authority with respect to all such plans.
Annual Development Plan. 7.1 The Parties shall prepare an Annual Development Plan for each element of the Services at least four (4) weeks before the start of the Financial Year. The Annual Development Plan shall:
(a) set out the agreed Aims and Outcomes for the specific Services;
(b) describe any changes or development required for the specific Services and how those changes will be delivered;
(c) provide information on how changes in funding or resources may impact the specific Services; and
(d) include details of the estimated Authority’s Financial Contribution due from the Authority for each Service.
7.2 The Annual Development Plan shall commence on 1 April at the beginning of the Financial Year and shall continue for twelve (12) months.
7.3 The Annual Development Plan may be varied by written agreement between the Parties. Any variation that increases or reduces the number or level of Services in the scope of the Agreement may require the Parties to make corresponding adjustments to the Authority's Financial Contribution.
7.4 If the Parties cannot agree the contents of the Annual Development Plan, the matter shall be dealt with in accordance with clause 34. Pending the outcome of the dispute resolution process or termination of the Agreement under clause 35, the Authority shall make available an amount equivalent to the Authority’s Financial Contribution for the previous Financial Year.
Annual Development Plan. 10.1 The Partners shall develop an Annual Development Plan, in order to implement their joint strategic plans, for each of the Services at least four weeks before the start of the Financial Year. The Annual Development Plan shall:
(a) set out the agreed Aims and Outcomes for the specific Services;
(b) describe any changes or development required for the specific Services;
(c) provide information on how changes in funding or resources may impact the specific Services; and
(d) include details of the estimated contributions due from each Partner for each Service and its designation to the Pooled and/or Non Pooled Fund.
10.2 The Annual Development Plan shall commence on 1st April at the beginning of the Financial Year and shall continue for 12 months.
10.3 The Annual Development Plan may be varied by written agreement between the Partners. Any variation that increases or reduces the number or level of Services in the scope of the Agreement shall require the Partners to make corresponding adjustments to the NHS body’s Financial Contribution and the Council’s Financial Contribution.
10.4 If the Partners cannot agree the contents of the Annual Development Plan, the matter shall be dealt with in accordance with Clause 23. Pending the outcome of the dispute resolution process or termination of the Agreement under Clause 23, the Partners shall make available amounts equivalent to the Financial Contributions for the previous Financial Year.
Annual Development Plan. 15.1 The Partners shall prepare a draft Annual Development Plan for each of the Services at least four weeks before the start of the Financial Year. The final plan will be agreed no later than 31 May each year. The Annual Development Plan shall:
15.1.1 set out the agreed Aims and Outcomes for the specific Services;
15.1.2 describe any changes or development required for the specific Services;
15.1.3 provide information on how changes in funding or resources may impact the specific Services; and
15.1.4 include details of the estimated contributions due from each Partner for each Service and its designation to the Pooled Fund.
15.2 The Annual Development Plan shall commence on 1 April at the beginning of the Financial Year and shall continue for 12 months.
15.3 The Annual Development Plan may be varied by written agreement between the Partners. Any variation that increases or reduces the number or level of Services in the scope of the Agreement shall require the Partners to make corresponding adjustments to the NHS body's Financial Contribution and the Council's Financial Contribution.
15.4 If the Partners cannot agree the contents of the Annual Development Plan, the matter shall be dealt with in accordance with Clause 34.
15.5 The Partners shall agree an Annual Development Plan in respect of the HESC Scheme within [insert time period] from the Commencement Date.
Annual Development Plan. Not later than [**] days after December 31 of each Calendar Year, Licensee shall submit to Merck an updated Development Plan for the pending Calendar Year. Such update shall take into account completion, commencement, changes in or cessation of Development activities not contemplated by the then-current Development Plan in sufficient detail to reflect the continued diligence of Licensee and shall reflect effort and resources consistent with other priority projects of Licensee. Merck shall have the right to comment on such annual plan. In the event Merck reasonably disagrees with the plan, Licensee shall consider in good faith Merck’s comments for revising the plan. At Merck’s written request, the President of Merck’s research division, or his designee, and the President of Licensee’s research division or equivalent position, or her designee, shall meet to discuss such comments. Any revision of the annual plan shall be submitted to Merck promptly after its completion.
